Tirzepatide Leads to Long-Term Glucose Control and Weight Loss in Type 2 Diabetes

Research highlights the sustained effects of tirzepatide on glucose control and weight loss over a two-year period.

Sep 26, 2024

∙ Paid

A positive and hopeful scene of a healthcare professional discussing a treatment plan with a patient who has type 2 diabetes. The healthcare setting is modern, with clear medical charts displaying improved glucose levels and weight loss statistics. The patient is smiling, holding a small pamphlet about a new diabetes treatment. The environment reflects optimism, with bright natural lighting and comfortable seating, symbolizing a successful and encouraging healthcare experience.

Topline:
A new study from the SURPASS-4 trial reveals that tirzepatide helps maintain glucose control and weight loss for up to two years in patients with type 2 diabetes. Approximately 80% of participants who initially achieved glycemic control or weight loss at 52 weeks maintained these improvements at 104 weeks.

Study Details:
The SURPASS-4 trial focuse…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.